Get the Stockscreener App
0.6619
1.83%
0.0119
Assertio Holdings Inc stock is traded at $0.6619, with a volume of 307.26K.
It is up +1.83% in the last 24 hours and down -0.59% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$0.65
Open:
$0.6402
24h Volume:
307.26K
Relative Volume:
0.93
Market Cap:
$63.30M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
-0.3277
EPS:
-2.02
Net Cash Flow:
$70.07M
1W Performance:
+0.15%
1M Performance:
-0.59%
6M Performance:
-28.47%
1Y Performance:
-36.96%
1-Day Range:
$0.6376
$0.6699
1-Week Range:
$0.603
$0.6704
52-Week Range:
$0.5137
$1.798
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
0.6619 | 63.30M | 169.43M | -186.01M | 70.07M | -2.02 |
|
RGC
Regencell Bioscience Holdings Ltd
|
78.00 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
161.67 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.50 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.89 | 47.60B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.89 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Jane Street Group LLC Decreases Position in Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World
Two Sigma Investments LP Raises Position in Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World
Millennium Management LLC Trims Holdings in Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World
Assertio Holdings, Inc. (NASDAQ:ASRT) Shares Sold by Two Sigma Advisers LP - Defense World
Northern Trust Corp Purchases 39,906 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World
Assertio (NASDAQ:ASRT) Stock Rating Lowered by Wall Street Zen - Defense World
Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025 - The Globe and Mail
Assertio’s (ASRT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Assertio CEO Fireside Chat: Exclusive Healthcare Insights Coming May 21How to Watch Live - Stock Titan
Stifel Financial Corp Buys New Stake in Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World
Picton Mahoney Asset Management Announces Monthly Distribution for Picton Mahoney Fortified Income Alternative Fund Exchange Traded Fund Units, Picton Mahoney Fortified Special Situations Alternative Fund Exchange Traded Fund Units, Picton Maho - The Globe and Mail
Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Assertio outlines 2025 transformation priorities and maintains $108M–$123M revenue guidance while reducing legal exposure - MSN
Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2025 Earnings Call Transcript - Insider Monkey
Assertio (ASRT) Price Target Cut by Alliance Global Partners Following Q1 Report | ASRT Stock News - GuruFocus
Assertio (NASDAQ:ASRT) Downgraded to “Hold” Rating by StockNews.com - Defense World
Assertio Reports First Quarter 2025 Financial Results - The Manila Times
Assertio Therapeutics Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Assertio reports Q1 2025 loss, stock dips post-earnings - Investing.com Canada
Why EchoStar Stock Plummeted by Over 16% Today - The Globe and Mail
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Assertio Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Assertio: Q1 Earnings Snapshot - San Antonio Express-News
Levi & Korsinsky Reminds Assertio Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 5, 2024ASRT - ACCESS Newswire
Assertio Holdings (ASRT) Plans Q1 Earnings Announcement - GuruFocus
Shareholders that lost money on Assertio Holdings, Inc.(ASRT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Assertio Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 5, 2024ASRT - ACCESS Newswire
Shareholders that lost money on Assertio Holdings, Inc. (ASRT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders that lost money on Assertio Holdings, Inc.(ASRT) should contact Levi & Korsinsky about pending Class ActionASRT - ACCESS Newswire
Assertio Holdings, Inc. Class Action: Levi & Korsinsky Reminds Assertio Holdings Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 5, 2024ASRT - ACCESS Newswire
Assertio Therapeutics to pay $3.6mln over alleged fentanyl product marketing violations, US DOJ says - marketscreener.com
Transcript : Assertio Holdings, Inc.Shareholder/Analyst Call - marketscreener.com
Balance Sheet Dive: Assertio Holdings Inc (ASRT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
73,909 Shares in Assertio Holdings, Inc. (NASDAQ:ASRT) Purchased by Marshall Wace LLP - Defense World
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 - GlobeNewswire
Assertio to Reveal Q1 2025 Results and New Strategic Roadmap on May 12 - Stock Titan
SHAREHOLDER ALERT: Potential Recovery for Assertio Holdings, Inc. (ASRT) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Assertio (ASRT) Projected to Post Earnings on Monday - Defense World
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Assertio Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineASRT - ACCESS Newswire
Assertio Holdings Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Assertio Holdings, Inc. (NASDAQ:ASRT) Position Raised by Geode Capital Management LLC - Defense World
Argo and City of Brampton Announce $10.9 Million Smart Transit Partnership - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):